Oncomatryx Biopharma SL:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Oncomatryx Biopharma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11186
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Oncomatryx Biopharma SL (Oncomatryx) is a developer of precision drugs. The company offers precision drugs that targets proteins located in the tumor environment. It develops therapeutic antibody-drug conjugates, antibodies, and human-derived proteins, which targets tumor associated stroma. Oncomatryx’s products comprise DMTX invaScan, DMTX bladderScan, DMTX breastScan, and companion diagnostics, among others. The company offers sensitive and specific monoclonal antibodies for the diagnosis of invasive carcinomas, among others. It markets its products through a network of distributors in Spain and abroad. Oncomatryx is headquartered in Derio, Spain.

Oncomatryx Biopharma SL – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Oncomatryx Biopharma SL, Medical Devices Deals, 2012 to YTD 2018 9
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Oncomatrix Enters Into Co-Development Agreement With University Of Stuttgart For Tumor Metastases Drugs 11
Licensing Agreements 12
Oncomatrix Enters Into Licensing Agreement With National Jewish Health For Cystatin-C Intellectual Property 12
Equity Offering 13
Oncomatryx Biopharma Raises USD5 Million in Equity Financing 13
Oncomatryx Biopharma SL – Key Competitors 14
Oncomatryx Biopharma SL – Key Employees 15
Oncomatryx Biopharma SL – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Key Facts 2
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oncomatryx Biopharma SL, Deals By Therapy Area, 2012 to YTD 2018 8
Oncomatryx Biopharma SL, Medical Devices Deals, 2012 to YTD 2018 9
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Oncomatrix Enters Into Co-Development Agreement With University Of Stuttgart For Tumor Metastases Drugs 11
Oncomatrix Enters Into Licensing Agreement With National Jewish Health For Cystatin-C Intellectual Property 12
Oncomatryx Biopharma Raises USD5 Million in Equity Financing 13
Oncomatryx Biopharma SL, Key Competitors 14
Oncomatryx Biopharma SL, Key Employees 15

List of Figures
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Oncomatryx Biopharma SL, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Oncomatryx Biopharma SL:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Boehringer Ingelheim GmbH:企業の戦略・SWOT・財務分析
    Boehringer Ingelheim GmbH - Strategy, SWOT and Corporate Finance Report Summary Boehringer Ingelheim GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Lietuvos energijos gamyba, AB (LNR1L)-エネルギー分野:企業M&A・提携分析
    Summary Lietuvos energijos gamyba, AB (Lietuvos), a subsidiary of Lietuvos Energija UAB, is a state-controlled electric utility that generates, imports and exports, and supplies electricity and thermal energy. It generates electricity from hydro, thermal and renewable energy sources. The company tra …
  • Aratana Therapeutics Inc (PETX):製薬・医療:M&Aディール及び事業提携情報
    Summary Aratana Therapeutics Inc (Aratana) is a provider of pet care solutions. The company develops, commercializing and markets biopharmaceutical products for medical condition in cats and dogs. Its pipeline portfolio consists of small molecule pharmaceuticals and large molecule biologics that aim …
  • Development Bank of Japan Inc:企業のM&A・事業提携・投資動向
    Development Bank of Japan Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Development Bank of Japan Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Barrick Gold Corporation:企業のM&A・事業提携・投資動向
    Barrick Gold Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Barrick Gold Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Abbott Molecular Inc-医療機器分野:企業M&A・提携分析
    Summary Abbott Molecular Inc (Abbott Molecular), a subsidiary of Abbott Laboratories is a medical diagnostic company that provides molecular testing solutions. The company’s products include infectious disease products, oncology products, genetics products, automation products, molecular diagnostics …
  • UGL Ltd:企業の戦略的SWOT分析
    UGL Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Seoul National University Hospital:製薬・医療:M&Aディール及び事業提携情報
    Summary Seoul National University Hospital (SNUH) is a healthcare service provider. It operates as the representative medical center of Korea. The hospital focuses on raising the standards of nation’s healthcare system, medical education, research and patient care. It offers services such as outpati …
  • TransGlobe Energy Corp (TGL):石油・ガス:M&Aディール及び事業提携情報
    Summary TransGlobe Energy Corp (TransGlobe Energy) is an oil and gas company that explores, develops and produces crude oil and natural gas. The company develops oil and natural gas properties in the Arab Republic of Egypt and the Republic of Yemen. It holds interests in various production sharing c …
  • El Paso Electric Company (EE)-エネルギー分野:企業M&A・提携分析
    Summary El Paso Electric Company (El Paso) is a vertically integrated electric utility which generates, transmits, and distributes electric power. It produces electricity from nuclear, natural gas, coal, and solar sources. The company has ownership interest in and operates various power generation f …
  • Bio-Reference Laboratories Inc:企業の戦略的SWOT分析
    Bio-Reference Laboratories Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • P2P Global Investments PLC (P2P):企業の財務・戦略的SWOT分析
    P2P Global Investments PLC (P2P) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Veritas (India) Ltd:企業の戦略・SWOT・財務分析
    Veritas (India) Ltd - Strategy, SWOT and Corporate Finance Report Summary Veritas (India) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • AGL Energy Ltd (AGL)-エネルギー分野:企業M&A・提携分析
    Summary AGL Energy Limited (AGL) is an integrated energy company that owns, operates and develops energy assets and provides natural gas, electricity, solar photovoltaic solutions and related products and services. The company’s power generation portfolio includes coal, gas, hydro, wind, solar, land …
  • BBB Technologies Inc:企業の製品パイプライン分析
    Summary BBB Technologies Inc (BBB Tech) is a development-stage medical technology company that develops medical devices and applications that facilitate the early diagnosis of metabolic and cardiovascular disorders. It discovers and develops single-drop and mobile integrated diagnostic tools for blo …
  • Hainan Airlines Co Ltd:企業の戦略・SWOT・財務情報
    Hainan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Hainan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • MOL Hungarian Oil and Gas Plc (MOL):企業の財務・戦略的SWOT分析
    MOL Hungarian Oil and Gas Plc (MOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Cydan Development Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cydan Development Inc (Cydan) is an orphan drug accelerator dedicated to advancing therapies for rare genetic diseases. The company identifies assets with biology and proof-of-concept data in vivo models from academic circles, industry, and other sources. It offers various technology platfor …
  • PRA Health Sciences Inc (PRAH):企業の財務・戦略的SWOT分析
    Summary PRA Health Sciences Inc (PRA) is a contract research organization (CRO) which provides clinical development services. The company offers services which include phase I-IV study management, bioanalytical services, biometrics, clinical pharmacology, strategic solutions, post-marketing research …
  • Tethys Oil AB (TETY):企業の財務・戦略的SWOT分析
    Summary Tethys Oil AB (Tethys Oil) is an upstream oil and gas company that offers exploration, development and production of oil and natural gas reserves. The company holds onshore exploration licences in Lithuania and France. Tethys Oil holds Gargzdai license, Rietavas license and Raseiniai license …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆